Abstract:Purpose: As the duration of lifetime survival after organ transplantation continues to increase, the consequences of long-term immunosuppression, such as opportunistic and rare infections, are a high-risk reality. This study examined upper extremity infections in the transplant population to determine the current clinical risk profile, management, and outcomes. Methods: An institutional database of 16,640 patients who underwent transplantation was queried for upper extremity infections from 2005 to 2017, defined as the presence of infection from the shoulder to the fingertips. The resulting data were analyzed using multivariable linear and logistic regression modeling. Results: A total of 230 eligible patients experienced upper extremity infections at a mean age of 54.1 ± 15.3 years, occurring, on average, 7.9 ± 8.6 years after transplantation. The most commonly transplanted organ was the kidney (51.3%), followed by the liver (20%). The most common location of infection was the forearm (31.7%), digits (27.4%), and upper arm (17%). The most common types of infection were cellulitis (69.1%), abscess (33.5%), joint sepsis (6.5%), infectious tenosynovitis (3.9%), and osteomyelitis (1.3%). Patients taking an antifungal medication, those who had a joint infection, or those who had undergone lung transplantation had an approximately 2.5-day longer stay in the hospital. For every 1-year increase in age at the time of transplantation, the time from transplantation to infection decreased by 0.21 years. Those who had undergone bone marrow transplantation or those who were taking tacrolimus were expected to have approximately 8- and 6-year decreases, respectively, in the time from transplantation to infection. Conclusions: Upper extremity infections should be individually evaluated and treated because of the heterogeneity of transplant type, immunosuppression medications, the age of the patient, and infection characteristics. Type of study/level of evidence: Prognostic IV.

Infection in the organ transplant recipient: an overview

Infection in Organ Transplantation

SARS-CoV-2 Infection in Transplant-Related Biology: Where Do We Stand?

Recent advances in understanding and managing infectious diseases in solid organ transplant recipients

Infections in Kidney and Pancreas Transplantation

Diagnosis, Prevention, and Treatment of Infections in Kidney Transplantation

Fungal Infection in Organ Transplant Patients

Analysis of Correlative Factors in Infection of Liver Transplant Recipients.

Clinical approach to donor‐derived infection in solid organ transplant recipients

A clinical analysis of post-renal transplant pulmonary infection

The Spectrum of Infectious Diseases in Kidney Transplantation: A Review of the Classification, Pathogens and Clinical Manifestations

Transplantation: current developments and future directions

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)

Common viral infections and associated dermatoses in organ transplant recipients

Immunopathology of lung transplantation: from infection to rejection and vice versa

The changing landscape of infections in the lung transplant recipient

Bacterial infections in solid organ transplant recipients

Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial

Upper Extremity Infections in the Transplant Population

Fungal infections in transplant and oncology patients

Parasitic infections in transplant recipients